Status:
RECRUITING
Multiparametric MRI for Characterization of Hepatocellular Carcinoma
Lead Sponsor:
University Hospital Muenster
Conditions:
Hepatocellular Carcinoma (HCC)
Eligibility:
All Genders
18+ years
Brief Summary
This prospective observational study investigates using multiparametric magnetic resonance imaging (MRI) to improve the characterization and management of therapy for hepatocellular carcinoma (HCC). T...
Detailed Description
This prospective, monocentric, observational study evaluates the clinical utility of multiparametric magnetic resonance imaging (mpMRI) in the characterization and management of hepatocellular carcino...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Confirmed or suspected diagnosis of HCC
- Scheduled to receive TACE or SIRT as part of standard clinical care
- Eligibility for liver MRI
- Willing and able to provide written informed consent
Exclusion
- Contraindications to MRI (e.g., pacemakers, ferromagnetic implants, severe claustrophobia)
- Known allergy or intolerance to gadolinium-based contrast agents
- Renal insufficiency with estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73m²
- Pregnancy or breastfeeding
- Inability to provide informed consent
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2028
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT06999174
Start Date
May 1 2025
End Date
May 1 2028
Last Update
July 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic of Radiology, University of Münster
Münster, Germany